Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial.
Rob A VergeerMark R PostmaIris SchmidtAstrid Gw Korsten-MeijerRobert A FeijenSchelto KruijffWouter B NagengastJ Marc C van DijkWilfred F A den DunnenAndré P van BeekJos M A KuijlenGerrit van den BergPublished in: BMJ open (2021)
NCT04212793.
Keyphrases
- study protocol
- clinical trial
- phase iii
- phase ii
- open label
- placebo controlled
- randomized controlled trial
- minimally invasive
- double blind
- ultrasound guided
- coronary artery bypass
- loop mediated isothermal amplification
- surgical site infection
- coronary artery disease
- metastatic colorectal cancer
- energy transfer
- sensitive detection